FutureWise Research, a leading healthcare and life sciences market intelligence firm, today announces the release of its ...
Technological Advancements Drive Innovation in Medical Radiation Shielding SolutionsThe Global Medical Radiation Shielding ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal ...
ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, today announced the launch of its latest product: CHO cell–derived recombinant ...
The "Global Quantum Technology Market 2026-2046" report has been added to ResearchAndMarkets.com's offering.The global quantum technology market represents one of the most dynamic and strategically ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc.
Adults with Duchenne muscular dystrophy demonstrated functional improvements exceeding natural history, following 28-day treatment with SAT-3247Grip strength increased 118.6% and predicted forced ...
The "Saudi Arabia Essential Oils Market by Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Saudi Arabia Essential Oils Market ...
PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Some companies tiptoe into innovation. Healthcare Triangle Inc. (NASDAQ:HCTI) prefers to kick the door down. The Pleasanton-based digital health ...
FRAMINGHAM, MA / ACCESS Newswire / October 10, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of aTyr Pharma, Inc. (NASDAQ: ATYR) common stock ...